2340
R. Bhattacharya, T. Pathak / Carbohydrate Research 344 (2009) 2336–2341
3.6. Methyl 2-O-benzyl-3,4,6-trideoxy-3-benzylamino-4-
(4-methylphenyl)-sulfonyl- -gulopyranoside 7
added dropwise to the reaction mixture. The resulting solution
was then heated under reflux with continuous stirring under N2
for 12 h. The reaction mixture was cooled to room temperature
and the volatile matters were evaporated under reduced pressure.
The residue obtained was triturated with EtOAc (30 mL). The or-
ganic layer was washed with satd aq solution of NH4Cl
(3 ꢁ 30 mL) and separated. The organic layer was dried over anhyd
Na2SO4, filtered, and the filtrate was evaporated under reduced
pressure to get a residue. The crude residue was purified by col-
umn chromatography over silica gel to obtain 11. (0.13 g, 73%).
[Eluent: EtOAc/pet ether (1:4)]. White crystalline solid. Mp: 137–
a-D
A mixture of 1 (0.2 g, 0.5 mmol) and neat benzylamine (3 mL)
was heated at 90 °C for 16 h with continuous stirring under N2.
The reaction mixture was cooled to room temperature and the vol-
atile matters were evaporated under reduced pressure. The residue
obtained was dissolved in EtOAc (30 mL). The EtOAc layer was
washed with satd aq solution of NH4Cl (3 ꢁ 30 mL) and separated.
The organic layer was then dried over anhydrous Na2SO4, filtered,
and the filtrate was evaporated under reduced pressure to get a
residue. The crude residue was purified by column chromatogra-
phy over silica gel to get 7 (0.136 g, 79%). [Eluent: EtOAc/pet ether
139 °C. ½a 2D8
ꢂ
+34.3 (c 0.625, CHCl3). 1H NMR (CDCl3): d 1.30 (d,
3H, J = 6.4 Hz); 2.46 (s, 3H); 2.87–2.94 (m, 1H); 3.18 (s, 3H);
3.49–3.55 (m, 2H); 3.88–3.92 (m, 1H); 4.47 (d, 1H, J = 3.2 Hz);
4.55 (dd, 2H, J = 11.6, 18.4 Hz); 5.06–5.10 (m, 1H); 5.19–5.24 (m,
1H); 7.29–7.40 (m, 7H); 7.76 (d, 2H, J = 8.0 Hz). 13C NMR: d 21.1,
21.6, 34.8, 55.2, 62.9, 66.0, 72.6 (CH2), 73.8 (CH2), 75.4, 95.2,
128.2, 128.3, 128.6, 128.8, 130.1, 135.0, 137.1, 145.5. Anal. Calcd
for C22H27NO7Sꢀ0.5H2O: C, 64.90; H, 6.19; N, 2.07. Found: C,
64.90; H, 5.99; N, 1.95.
(1:3)] White crystalline solid. Mp: 127–129 °C. ½a D28
ꢂ
+34.1 (c 0.625,
CHCl3). 1H NMR (CDCl3): d 1.51 (d, 3H, J = 6.8 Hz); 2.44 (s, 3H),
3.15–3.16 (m, 1H), 3.28–3.30 (m, 1H), 3.41 (s, 3H); 3.57 (dd, 2H,
J = 13.6, 36.0 Hz), 3.99–4.02 (m, 1H); 4.37 (dd, 2H, J = 12.4,
32.8 Hz); 4.69–4.72 (m, 1H); 4.74 (d, 1H, J = 3.6 Hz); 7.01–7.02
(m, 2H); 7.19–7.26 (m, 7H); 7.29–7.36 (m, 3H); 7.46 (d, 2H,
J = 8.0 Hz). 13C NMR: d 18.4, 21.8, 52.7 (CH2), 52.8, 55.3, 60.7,
68.8 (CH2), 75.0, 96.0 (CH), 101.2 (CH), 118.0 (C), 120.6 (CH and
C), 122.8 (C), 126.6 (CH), 128.3 (CH), 129.1 (CH), 138.5 (C). 160.6
(C). Anal. Calcd for C28H33NO5Sꢀ0.5CH3OH: C, 62.45; H, 6.77; N,
3.03. Found: C, 62.63; H, 5.51; N, 2.96.
3.10. Methyl 2-O-benzyl-3,4,-trideoxy-3-C-
bis(methoxycarbonyl)methyl-4-(4-methylphenyl)-
sulfonyl-D-glucopyranoside 14
3.7. Methyl 2-O-benzyl-3,4,6-trideoxy-3-(n-butyl)amino-4-
(4-methylphenyl)-sulfonyl-a-D-gulopyranoside 8
Compound 1 (0.2 g, 0.5 mmol) was treated with dimethylmalo-
nate (0.15 mL, ꢃ2.5 mmol) following the procedure described for
the preparation of 11 to get compound 12 within 10 h. (0.14 g,
78%). [Eluent: EtOAc/pet ether (2:7)] White crystalline solid. Mp:
Compound 1 (0.2 g, 0.5 mmol) was treated with neat n-butyl-
amine (3 mL) at 80 °C following the procedure described for 7 to
get compound 8 within 14 h (0.142 g, 83%). [Eluent: EtOAc/pet
142–144 °C. ½a 2D8
ꢂ
+37.1 (c 0.625, CHCl3). 1H NMR (CDCl3): d 1.45
(d, 3H, J = 5.6 Hz); 2.45 (s, 3H); 2.99–3.05 (m, 4H); 3.14–3.20 (m,
1H); 3.47 (s, 3H); 3.79 (s, 3H); 3.80–3.84 (m, 1H); 4.22 (d, 1H,
J = 2.8 Hz); 4.26–4.35 (m, 2H); 4.45 (d, 1H, J = 11.6 Hz); 4.77 (d,
1H, J = 3.2 Hz); 7.22–7.29 (m, 5H); 7.37 (d, 2H, J = 8.0 Hz); 7.77
(d, 2H, J = 8.0 Hz). 13C NMR: d 21.6, 21.9, 36.4, 49.6, 52.2, 52.3,
54.9, 62.6, 68.2, 72.8 (CH2), 75.0, 95.6, 127.9, 128.2, 128.6, 129.3,
129.8, 134.1, 137.7, 145.1. Anal. Calcd for C26H32O9Sꢀ0.5H2O: C,
62.67; H, 5.59. Found: C, 62.40; H, 5.82.
ether (1:4)]. White crystalline solid. Mp: 123–125 °C. ½a D28
ꢂ
+28.1
(c 0.625, CHCl3). 1H NMR (CDCl3): d 0.80 (t, 3H, J = 6.8 Hz); 1.14–
1.18 (m, 5H); 1.52 (d, 3H, J = 7.2 Hz); 2.31–2.34 (m, 2H); 2.43 (s,
3H), 3.22–3.25 (m, 2H), 3.39 (s, 3H); 4.00–4.02 (m, 1H), 4.58–
4.64 (m, 3H); 4.71 (d, 1H, J = 3.6 Hz); 7.26–7.38 (m, 7H); 7.66 (d,
2H, J = 8.4 Hz). 13C NMR: d 13.9, 18.3, 20.3 (CH2), 21.7, 31.9 (CH2),
49.0 (CH2), 54.2, 55.9, 61.0, 67.8, 71.3, 71.6 (CH2), 98.9, 128.0,
128.1, 128.2, 128.5, 129.7, 137.7, 137.8, 144.5. Anal. Calcd for
C25H36NO5Sꢀ0.5CH3OH: C, 65.62; H, 7.40; N, 2.89. Found: C,
65.69; H, 7.57; N, 2.79.
Acknowledgments
T.P. thanks the Indo-French Centre for the Promotion of Ad-
vanced Research, New Delhi for funding (Project No. 3405-1). R.B.
thanks CSIR, New Delhi for a fellowship. DST is also thanked for
the creation of 400 MHz facility under IRPHA program and DST-
FIST for single crystal X-ray facility.
3.8. Methyl 2-O-benzyl-3,4,6-trideoxy-3-(N-benzoyl)amino-4-
(4-methylphenyl)-sulfonyl-a-D-gulopyranoside 10
Compound 1 (0.2 g, 0.5 mmol) was treated with aq ammonia at
room temperature to get compound 9 within 36 h. Compound 9
was benzoylated using standard procedure to afford 10 (0.18 g,
88% from 1). [Eluent: EtOAc/pet ether (1:6)]. Colorless jelly. ½a D28
ꢂ
Supplementary data
+54.1 (0.625, THF). 1H NMR (CDCl3): d 1.58 (d, 3H, J = 6.8 Hz);
2.46 (s, 3H), 3.51 (s, 3H); 3.75–3.77 (m, 1H), 4.29–4.31
(m, 1H); 4.46–4.58 (m, 3H); 4.65–4.69 (m, 1H); 4.49 (d, 1H,
J = 3.6 Hz); 7.26–7.34 (m, 5H); 7.38–7.52 (m, 5H); 7.70 (d, 2H,
J = 7.2 Hz); 7.83 (d, 2H, J = 8.4 Hz). 13C NMR: d 18.4, 21.8, 46.7,
56.2, 60.9, 64.9, 69.3, 70.9 (CH2), 99.3, 127.0, 128.0, 128.2
(2 ꢁ CH), 128.6, 128.7, 130.0, 131.9, 133.6, 137.0, 137.1, 145.0,
167.0. Anal. Calcd for C28H31NO6Sꢀ0.5H2O: C, 63.40; H, 5.60; N,
2.76. Found: C, 63.22; H, 5.62; N, 2.29.
Complete crystallographic data for the structural analysis have
been deposited with the Cambridge Crystallographic Data Centre,
CCDC Nos. 742104–742106. Copies of this information may be ob-
tained free of charge from the Director, Cambridge Crystallographic
Data Centre, 12 Union Road, Cambridge, CB21EZ, UK. (fax: +44-
1223-336033, e-mail: deposit@ccdc.cam.ac.uk or via: www.
associated with this article can be found, in the online version, at
3.9. Methyl 2-O-benzyl-3,4,6-trideoxy-3-C-nitromethyl-4-
(4-methylphenyl)-sulfonyl-a-D-glucopyranoside 11
References
t
1. Collins, P. M.; Ferrier, R. J. Monosaccharides: Their Chemistry and Their Roles in
Natural Products; John Wiley & Sons: Chichester, 1996.
2. Ferrier, R. J. Carbohydrate Chemistry: Monosaccharides, Disaccharides and Specific
Oligosaccharides; The Royal Society of Chemistry: Cambridge, 1968–2001; Vols.
1–32.
To a suspension of 90% BuOK (0.33 g, 2.94 mmol) in dry THF
(5 mL) at 0 °C was added CH3NO2 (0.15 mL, ꢃ2.5 mmol) and the
resulting solution was stirred for 15 min. at that temperature un-
der N2. A solution of 1 (0.2 g, 0.5 mmol) in dry THF (10 mL) was